跳至主要内容
临床试验/CTRI/2024/05/066737
CTRI/2024/05/066737尚未招募4 期

Ideal time for administration of prophylactic tranexamic acid for reducing blood loss and preventing postpartum hemorrhage in cesarean delivery in a tertiary health care centre: A single-centre, double-blind, randomized controlled non-inferiority trial. - NI

AIIMS, Bhubaneswar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a)Women undergoing elective or emergency LSCS.
  • b)Gestational age = 32weeks.

排除标准

  • a)History of previous thrombotic event or preexisting pro-thrombotic disease.
  • b)Any active or chronic cardiovascular disease except for hypertension.
  • c)Any chronic or active kidney disease or insufficiency.
  • d)Chronic or active liver disease.
  • e)Autoimmune disease.
  • f)Sickle cell disease.
  • g)Placenta accreta/increta/percreta.
  • h)Eclampsia, HELLP syndrome
  • i)Received antiplatelet drugs during the week before delivery.
  • j)Known allergy to tranexamic acid.
  • k)Women who develop PPH before cord clamping

研究者

相似试验